Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Other Non-Current Assets (2018 - 2025)

Inventiva (IVEVF) posted Other Non-Current Assets of $1.4 million for Q4 2025, up 14.13% on a QoQ basis from $1.2 million in Q2 2025, and up 20.9% year-over-year from $1.1 million in Q4 2024.

Analysis

Inventiva (IVEVF) Other Non-Current Assets (2018 - 2025) Analysis & Trends

Inventiva has reported Other Non-Current Assets for 8 years, with the latest figure at $1.4 million in Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 20.9% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 20.9% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 20.9% from the prior year.
  • Other Non-Current Assets was $1.4 million for Q4 2025 at Inventiva, up from $1.2 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $15.7 million in Q2 2024, with the low at $1.1 million in Q4 2024.
  • Average Other Non-Current Assets over 5 years is $5.0 million, with a median of $2.8 million recorded in 2021.
  • The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets soared 544.12% in 2023, then plunged 92.44% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $2.8 million in 2021, then plunged by 39.08% to $1.7 million in 2022, then jumped by 535.72% to $10.8 million in 2023, then tumbled by 89.66% to $1.1 million in 2024, then rose by 20.9% to $1.4 million in 2025.
  • The last three Other Non-Current Assets figures came in at $1.4 million (Q4 2025), $1.2 million (Q2 2025), and $1.1 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 14.27 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 10.73 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn 5.93 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 9.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 5.50 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn - 42.45 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 86.76 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 239.50 Mn
10 Inventiva 693.72 Mn 693.72 Mn - 1.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.35 Mn
Jun 30, 2025 1.19 Mn
Dec 31, 2024 1.12 Mn
Jun 30, 2024 15.67 Mn
Dec 31, 2023 10.82 Mn
Jun 30, 2023 11.20 Mn
Dec 31, 2022 1.70 Mn
Jun 30, 2022 1.74 Mn
Dec 31, 2021 2.79 Mn
Jun 30, 2021 4.15 Mn
Mar 31, 2021 3.32 Mn
Dec 31, 2020 2.03 Mn
Jun 30, 2020 4.56 Mn
Dec 31, 2019 3.47 Mn
Dec 31, 2018 2.71 Mn